Drugs / Uridine 5'-Triphosphate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00210080 | Apr 2001 → Dec 2003 | lung cancer | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Uridine 5'-Triphosphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00210080 ↗ |
| Known as | UTP | “Uridine 5'-Triphosphate (UTP) Solution for Inhalation” NCT00210080 ↗ |
| Route | Inhaled | “following a single inhaled dose of UTP” NCT00210080 ↗ |